Follow
Diane Havlir
Diane Havlir
Verified email at ucsf.edu
Title
Cited by
Cited by
Year
Prevention of HIV-1 infection with early antiretroviral therapy
MS Cohen, YQ Chen, M McCauley, T Gamble, MC Hosseinipour, ...
New England journal of medicine 365 (6), 493-505, 2011
87152011
Recovery of replication-competent HIV despite prolonged suppression of plasma viremia
JK Wong, M Hezareh, HF Gunthard, DV Havlir, CC Ignacio, CA Spina, ...
Science 278 (5341), 1291-1295, 1997
26101997
Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy
RM Gulick, JW Mellors, D Havlir, JJ Eron, C Gonzalez, D McMahon, ...
New England Journal of Medicine 337 (11), 734-739, 1997
24621997
The end of AIDS: HIV infection as a chronic disease
SG Deeks, SR Lewin, DV Havlir
The lancet 382 (9903), 1525-1533, 2013
21892013
Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections
V Appay, PR Dunbar, M Callan, P Klenerman, GMA Gillespie, L Papagno, ...
Nature medicine 8 (4), 379-385, 2002
19402002
Antiretroviral therapy for the prevention of HIV-1 transmission
MS Cohen, YQ Chen, M McCauley, T Gamble, MC Hosseinipour, ...
New England Journal of Medicine 375 (9), 830-839, 2016
18062016
Asymptomatic transmission, the Achilles’ heel of current strategies to control Covid-19
M Gandhi, DS Yokoe, DV Havlir
New England journal of medicine 382 (22), 2158-2160, 2020
13702020
HIV-Specific Cd8+ T Cells Produce Antiviral Cytokines but Are Impaired in Cytolytic Function
V Appay, DF Nixon, SM Donahoe, GMA Gillespie, T Dong, A King, ...
The Journal of experimental medicine 192 (1), 63-76, 2000
11392000
Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells
ZQ Zhang, T Schuler, M Zupancic, S Wietgrefe, KA Staskus, KA Reimann, ...
Science 286 (5443), 1353-1357, 1999
11321999
1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus
H Masur, JE Kaplan, KK Holmes, BL Alston, N Ampel, JR Anderson, ...
Clinical Infectious Diseases 30, S29-S65, 2000
906*2000
Class-sparing regimens for initial treatment of HIV-1 infection
SA Riddler, R Haubrich, AG DiRienzo, L Peeples, WG Powderly, ...
New England Journal of Medicine 358 (20), 2095-2106, 2008
8622008
Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy
DD Richman, D Havlir, J Corbeil, D Looney, C Ignacio, SA Spector, ...
Journal of virology 68 (3), 1660-1666, 1994
7551994
Tuberculosis in patients with human immunodeficiency virus infection
DV Havlir, PF Barnes
New England journal of medicine 340 (5), 367-373, 1999
7451999
Timing of antiretroviral therapy for HIV-1 infection and tuberculosis
DV Havlir, MA Kendall, P Ive, J Kumwenda, S Swindells, SS Qasba, ...
New England Journal of Medicine 365 (16), 1482-1491, 2011
7252011
Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial
B Grinsztejn, MC Hosseinipour, HJ Ribaudo, S Swindells, J Eron, ...
The Lancet infectious diseases 14 (4), 281-290, 2014
6282014
Prevalence and predictive value of intermittent viremia with combination HIV therapy
DV Havlir, R Bassett, D Levitan, P Gilbert, P Tebas, AC Collier, MS Hirsch, ...
Jama 286 (2), 171-179, 2001
4752001
Prophylaxis against Disseminated Mycobacterium avium Complex with Weekly Azithromycin, Daily Rifabutin, or Both
DV Havlir, MP Dubé, FR Sattler, DN Forthal, CA Kemper, MW Dunne, ...
New England Journal of Medicine 335 (6), 392-398, 1996
4261996
Viral dynamics of acute HIV-1 infection
SJ Little, AR McLean, CA Spina, DD Richman, DV Havlir
The Journal of experimental medicine 190 (6), 841-850, 1999
4091999
Effect of treatment, during primary infection, on establishment and clearance of cellular reservoirs of HIV-1
MC Strain, SJ Little, ES Daar, DV Havlir, HF Günthard, RY Lam, OA Daly, ...
The Journal of infectious diseases 191 (9), 1410-1418, 2005
3972005
High-dose nevirapine: safety, pharmacokinetics, and antiviral effect in patients with human immunodeficiency virus infection
D Havlir, SH Cheeseman, M Mclaughlin, R Murphy, A Erice, SA Spector, ...
Journal of Infectious Diseases 171 (3), 537-545, 1995
3851995
The system can't perform the operation now. Try again later.
Articles 1–20